Second author, Richard J. Santen, is with Univ. of Virginia, Charlottesville. Provides evidence of the endocrine effects of these aromatase inhibitors, demonstrates how these effects translate into clinical benefits, and explores other clinical indications for which aromatase inhibitors may be employed. Includes recent research findings.
